Altered Vascular Reactivity in Sickle Hemoglobinopathy

American Journal of Hypertension

Volumn 2, Issue 1, 1989, Pages 2-8

  Hatch, Fred E ^a   Crowe, Lee R ^a   Miles, Don E ^a   Young, Judy P ^a   Portner, Michael E ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Hypertension; Rennin; Sickle cell anemia; Sodium; Vascular reactivity

Indexed keywords

ANGIOTENSIN; RENIN;

ADULT; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; SICKLE CELL ANEMIA;

ADULT; ANEMIA, SICKLE CELL; ANGIOTENSIN II; ANIMAL; BLOOD PRESSURE; BLOOD VESSELS; DISEASE SUSCEPTIBILITY; FEMALE; HEMODYNAMICS; HUMAN; HYPERTENSION; MALE; NOREPINEPHRINE; PLETHYSMOGRAPHY; RENIN; SODIUM; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0024503269     PISSN: 08957061     EISSN: 19417225     Source Type: Journal    
DOI: 10.1093/ajh/2.1.2     Document Type: Article

References (36)

1. National Health Survey for years 1971-74. Vital and Health Statistic Series II. No 203. US Dept of HHS, Public Health Service, 1977.
2. Wheatley HC, Crowe LR, Moore et al JB: Low prevalence of hypertension in sickle hemoglobinopathy despite hyperreninemia. IX Intern Cong Neph (abst), 1984;230A.
3. Moore JB, Crowe LR, Wheatley et al HC,: Altered forearm hemodynamics in sickle anemia: A protective mechanism from HBP? IX Intern Cong Neph (abst), 1984;217A.
4. Johnson CS, Giorgio AJ: Arterial blood pressure in adults with sickle cell disease. Arch Intern Med 1981;141:891-893.
5. Cooperative study of sickle cell disease, (CSSSD), sickle cell branch of the National Heart, Lung and Blood Institute (unpublished data).
6. Radel EG, Kochen JA, Finberg L: Hyponatremia in sickle cell disease: A renal salt-losing state. J Pediatr 1976; 88:800-805.
7. de Jong PE, De Jong-van Den Berg, LTW, Donker, AJM, Statius van Eps LW: The role of prostaglandins and renin in sickle-cell nephropathy. Neth J Med 1978;21:67-72.
8. DeFronzo RA, Taufield PA, Black et al H: Impaired renal tubular potassium secretion in sickle cell disease. Ann Intern Med 1979;90:310-316.
9. de Jong PE, De Jong-van den Berg, LTW, Sewrajsingh et al GS: The influence of indomethacin on renal hemodynamics in sickle cell anemia. Clin Sci 1980;59:245-250.
10. Matustik MC, Chausmer AB, Meyer WJ: The effect of sodium intake on zinc excretion in patients with sickle cell anemia. Am Coll Nutrition 1982;1:331-336.
11. Katz MA, Janjan N, Swanson J: Forearm hemodynamics in volunteers and in untreated and treated hypertensive patients. Cardiovasc Med 1978;3:317-327.
12. Walser M, Davidson DG, Orloff J: The renal clearance of alkali-stable inulin. J Clin Invest 1955;34:1520-1523.
13. Smith HW, Finkelstein N, Aliminosa et al L: The renal clearances of substituted hippuric acid derivatives and other aromatic acids in dog and man. J Clin Invest 1945;24:388-404.
14. Retzloff JA: Red cell volume, plasma volume, and lean body mass in healthy men and women. The development of a blood volume standard. Thesis. Mayo Graduate School of Medicine, University of Minnesota, 1963.
15. Sealey JE, Gerten-Banes J, Laragh JH: The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int 1972;1:240-253.
16. Passon PG, Peuler JD: Simplified radiometric assay for plasma norepinephrine and epinephrine. Anal Biochem 1973;51:618-631.
17. Weidmann P, de Chatel R, Schiffmann et al A: Interrelations between age and plasma renin, aldosterone and cortisol, urinary catecholamines, and the body sodium/volume state in normal man. Klin Wschr 1977;55:725- 733.
18. de Jong PE, Landman H, Statius van Eps LW: Blood pressure in sickle cell disease. Arch Intern Med 1982;142:1239-1240.
19. Grell GAC, Alleyne GAO, Serjeant GR: Blood pressure in adults with homozygous sickle cell disease. Lancet 1981;2:1166.
20. Howard J, Holman BL: The effects of race and occupation on hypertensive mortality. Milbank Memorial Fund Quarterly 1970;48:263.
21. Leight L, Snider TH, Clifford GO, Hellems HK: Hemodynamic studies in sickle cell anemia. Circulation 1954;10:653-662.
22. Sproule BJ, Halden ER, Miller WF: A study of cardiopulmonary alterations in patients with sickle cell disease and its variants. J Clin Invest 1958;37:486-495.
23. Barreras L, Diggs LW, Lipscomb A: Plasma volume in sickle cell disease. South Med J 1966;59:456-458.
24. Carpentieri U, Matustik MC, Meyer WJ III: Hyperaldosteronism and urinary sodium loss in sickle cell anemia. Blood 1977;50(suppl 1):102.
25. Hatch FE, Culbertson JW, Diggs LW: Nature of the renal concentrating defect in sickle cell disease. J Clin Invest 1967;46(3):336-345.
26. Thurston H: Vascular angiotensin receptors and their role in blood pressure control. Am J Med 1976;61:768-778.
27. Devynck MA, Meyer P: Angiotensin receptors in vascular tissue. Am J Med 1976;61:758-767.
28. Aiken JW: Effects of prostaglandin synthesis inhibitors on angiotensin tachyphylaxis in the isolated coeliac and mesenteric arteries of the rabbit. Pol J Pharmacol Pharm 1974;26:217-227.
29. McGiff JC, Crowshaw K, Terragno NA, Lonigro AJ: Release of a prostaglandin-like substance into renal venous blood in response to angiotensin II. Circ Res 1970;26-27 (suppl 1):121-130.
30. McGiff JC, Crowshaw K, Terragno et al NA: Differential effect of noradrenaline and renal nerve stimulation on vascular resistance in the dog kidney and the release of a prostaglandin E-like substance. Clin Sci 1972;42:223-233.
31. Negus P, Tannen RL, Dunn MF: Indomethacin potentiates the vasoconstrictor actions of angiotensin II in normal man. Prostaglandins 1976;122:175-180.
32. Aiken JW, Vane JR: Intrarenal prostaglandin release attenuates the renal vasoconstrictor activity of angiotensin. J Pharmacol Exp Ther 1973;184:678-687.
33. Gryglewski RJ, Korbut R: Prostaglandin feedback mechanism limits vasoconstrictor action of norepinephrine in perfused rabbit ear. Experientia 1975;31:89-91.
34. McGiff JC, Vane JR: Prostaglandins and the regulation of blood pressure. Kidney Int 1975;8:262-270.
35. Vane JR, McGiff JC: Possible contributions of endogenous prostaglandins to the control of blood pressure. Circ Res 1975;36(suppl 1):68-75.
36. de Jong PE, Saleh AW, de Zeeuw et al D: Urinary prostaglandins in sickle cell nephropathy: A defect in 9-ketore- ductase activity? Clin Nephrol 1984;22(4):212-213.